FEDERICO CAMPOS: Open Payments
NPI 1497764294 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 7 payments from 6 companies in 2025. Trend: 2023 $542 · 2024 $952 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $234 |
| Abbott Laboratories | 1 | $176 |
| Madrigal Pharmaceuticals | 1 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $112 |
| Janssen Pharmaceuticals, Inc | 1 | $109 |
Products named: FREESTYLE LIBRE 3, REZDIFFRA, SPRAVATO, Epclusa.
Industry payments across CA — which companies pay providers there.
